SIGA · Siga Technologies Inc
Market Cap
$232.79M
Shares
71.85M
SIGA metrics
73 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$3.24
Market cap
$232.79M
Price action
19 metricsPrice change (1W)
+6.6%
Price change (30D)
+0.9%
Price change (3M)
-25.0%
Price change (6M)
-47.9%
Price change (YTD)
-47.0%
Price change (1Y)
-61.4%
Trailing year
Price change (5Y)
-50.5%
52-week high
$9.37
52-week low
$2.87
Change from 52-week high
-65.4%
Change from 52-week low
+12.9%
Annualized volatility
47.1%
Beta
0.7
RSI (14D)
54.8
Price vs SMA 50
-2.9%
Price vs SMA 200
-35.5%
Avg volume (3M)
685,099
Relative volume
1.6
Average dollar volume
$2.36M
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
71.85M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
4.3×
reciprocal yield 23.1%
P / book
1.4
reciprocal yield 71.0%
FCF yield
—
TTM · current market cap
Buyback yield
0.0%
P / FCF
—
P / operating cash flow
—
Earnings yield
-1.2%
Historical valuation
8 metricsP / E historical average (3Y)
9.8×
reciprocal yield 10.2%
P / E historical average (5Y)
11.9×
reciprocal yield 8.4%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
18.5%
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
$0.60
Dividend growth YoY
+0.0%
Dividend growth streak
—
Last ex-dividend
2026-04-07
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-06
Profitability
9 metricsGross margin
54.4%
Operating margin
-20.8%
Trailing 12 months
Net margin
-5.2%
Gross profit (TTM)
—
Operating profit (TTM)
−$11.14M
Net income (TTM)
−$2.79M
Trailing 12 months
Diluted EPS (TTM)
$-0.04
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-49.5%
Year over year
Net income growth YoY
-64.9%
Revenue (TTM)
$53.66M
Trailing 12 months
EPS growth YoY
-65.3%
Shares change YoY
+0.2%
Year over year · more shares
Revenue CAGR (3Y)
-5.1%
Revenue CAGR (5Y)
-5.4%
EPS CAGR (3Y)
-11.4%
EPS CAGR (5Y)
-14.7%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-1.7%
Return on assets
-1.6%
Debt / equity
—
Current ratio
21.7
EBITDA (TTM)
−$10.55M
Free cash flow (TTM)
—
Quick ratio
16.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$117.58M
Total assets
$175.74M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$20.17M
Capital expenditures (TTM)
$100,124
R&D (TTM)
$20.43M
SG&A (TTM)
$19.87M
Stock compensation (TTM)
$3.51M
R&D / revenue
38.1%
Stock compensation / revenue
6.5%
Ownership (13F)
3 metrics13F filers
162
13F filer change QoQ
-21
Institutional ownership
48.6%
Short interest
3 metricsShort interest
5.3%
Latest settlement · 6.6 days to cover
Days to cover
6.6d
Short-squeeze score
70 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1010086
CUSIP
826917106
13F (30d)
134 filings
134 filers
Visit website
Investor relations